CClinicalTrials.gg
Enrolling by invitationNCT06204367Updated Jan 12, 2024

Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis

An observational study in RSV Infection and Bronchiolitis, sponsored by Kırıkkale University. Enrolling by invitation at 1 site in Turkey. Open to participants aged Up to 30 Days. Per ClinicalTrials.gov, last updated 2024-01-12.

Sponsored by Kırıkkale University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
28
Ages
Up to 30 Days
Sex
All
01

Study summary

Respiratory Syncytial Virus (RSV) is a seasonal, highly contagious pathogen belonging to the Pneumoviridae (genus orthopneumovirus), a family of negative-strand RNA viruses. Lung ultrasonography; Today, it has become frequently used in neonatal intensive care units because it is a diagnostic, useful, harmless, radiation-free, bedside, reproducible and practical method. The primary purpose of the study is to record lung ultrasound findings and score and thus to compare the agreement between lung ultrasonography and clinical score in the diagnosis and follow-up of newborn babies who are followed up in the neonatal intensive care unit due to bronchiolitis caused by RSV and other viral factors, which are frequently encountered.

Read the detailed description

Respiratory Syncytial Virus (RSV) is a type of negative-strand RNA viruses. It is a seasonal, highly contagious pathogen belonging to the family Pneumoviridae (genus orthopneumovirus). RSV is a common cause of respiratory disease throughout life but is associated with significant morbidity and mortality, especially in infants and older adults.

RSV infections account for approximately 60% to 80% of bronchiolitis in infancy and 40% of pediatric pneumonias.

Bronchiolitis is an acute lower respiratory tract infection that affects children under one or two years of age and is the most common cause of hospitalization, according to American Academy of Pediatrics (AAP) guidelines. Diagnostic criteria for bronchiolitis are based on clinical history and examination.

Lung ultrasonography (LUS) was first used in adults in 1995, and in the last decade, lung ultrasound has proven to be a useful diagnostic tool in many pediatric and neonatal diseases, and its application and benefit in the treatment of bronchiolitis has been reported. Since AUS allows bedside assessment of the subpleural lung for density, thus reducing the quantitative ratio of airspace and space, it is reasonable to expect that a combination of clinical and ultrasound parameters may be useful. Studies have shown that qualitative and quantitative lung ultrasound findings suggest a relationship with the severity of bronchiolitis and are useful in the follow-up of patients.

Caiulo et al. They showed that AUS is a valuable tool in the diagnosis of bronchiolitis.

However, data on lung ultrasound in newborns with viral lower respiratory tract infections are quite limited.

Lung ultrasonography; Today, it has become frequently used in neonatal intensive care units because it is a diagnostic, useful, harmless, radiation-free, bedside, reproducible and practical method. In our clinic, lung ultrasonography is performed on babies hospitalized with respiratory distress. Images will be obtained using the linear probe of the device to be used for AUS. Brat et al. AUS scoring specified in the studies of Raimondi et al. and Raimondi et al. will be used.

Accordingly, both lungs will be evaluated as three areas on the right and left (anterior upper, anterior lower and lateral) and will be scored separately. Parasternal with anterior axillary line in front The area between the line is divided into two by the line passing from the nipple. The upper part is considered as the upper anterior region and the lower part is considered as the lower anterior region. The area in the middle of the anterior and posterior axillary lines is called the lateral region.

is evaluated. Each field is given a score of 0 to 3. If there were A lines, 0 points were given. If there were more than 3 B lines in an area, 1 point was given. If the B lines were very dense and there was no A line, it was evaluated as white lung and 2 points were given. If there was a consolidation image in AUS, 3 points were given. The total score was evaluated as a maximum of 18. In this study, newborn babies who were admitted and admitted to the Neonatal Intensive Care Unit of Kırıkkale University Faculty of Medicine Hospital with symptoms of viral lower respiratory tract diseases between 18/12/2023 and 01/06/2023 were clinically diagnosed with 40% of their O2 need at the 24th hour of hospitalization. Lung ultrasonography was planned to be performed in cases where the patient was overweight and/or required pressure or was intubated, and at the time of discharge. Demographic characteristics, symptoms, all routine laboratory and radiological imaging of newborn babies, and additional pathogen or pathogens will be obtained from the file information. The parameters to be recorded are shown in the Case Report Form. The primary purpose of the study is to record lung ultrasound findings and score and thus to compare the agreement between lung ultrasonography and clinical score in the diagnosis and follow-up of newborn babies who are followed up in the neonatal intensive care unit due to bronchiolitis caused by RSV and other viral factors, which are frequently encountered.

02

Conditions studied

  • RSV Infection
  • Bronchiolitis
03

Who can participate

Ages eligible
Up to 30 Days
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

newborn

Inclusion criteria

  • All newborns hospitalized with viral lower respiratory tract findings in the neonatal intensive care unit of Kırıkkale University Faculty of Medicine Hospital
  • Patients with study approval
  • Patients who underwent lung ultrasonography were included in the study.

Exclusion criteria

Exclusion Criteria:

  • Newborns who do not lie down due to viral lower respiratory tract infection
  • Patients without study consent
  • Patients for whom lung ultrasonography could not be performed
04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
28 participants (estimated)
Target follow-up
5 Months
Patient registry
Yes

Interventions

  • Diagnostic testLung Ultrasonografisi

    It is aimed to compare the agreement between lung ultrasonography and clinical score in the diagnosis and follow-up of newborn babies who are followed up in the neonatal intensive care unit due to bronchiolitis caused by frequently encountered RSV and other viral factors.

05

What researchers measure

Primary outcomes

  1. Lung ultrasonography

    It is aimed to compare the agreement between lung ultrasonography and clinical score in the diagnosis and follow-up of newborn babies who are followed up in the neonatal intensive care unit due to bronchiolitis caused by frequently encountered RSV and other viral factors.

    Time frame: 5 months

Secondary outcomes

  1. lung radrology

    The aim of using lung ultrasound in the clinical follow-up of newborn babies diagnosed with bronchiolitis caused by respiratory viral factors is to reduce the number of lung films and therefore reduce radiation exposure.

    Time frame: 5 months

06

Study locations

1 site
  • Kırıkkale University Faculty of Medicine
    Kırıkkale, 71000, Turkey
07

References and documents

Publications

  • Azzari C, Baraldi E, Bonanni P, Bozzola E, Coscia A, Lanari M, Manzoni P, Mazzone T, Sandri F, Checcucci Lisi G, Parisi S, Piacentini G, Mosca F. Epidemiology and prevention of respiratory syncytial virus infections in children in Italy. Ital J Pediatr. 2021 Oct 2;47(1):198. doi: 10.1186/s13052-021-01148-8. PubMed 34600591 ↗
  • Demont C, Petrica N, Bardoulat I, Duret S, Watier L, Chosidow A, Lorrot M, Kieffer A, Lemaitre M. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018. BMC Infect Dis. 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8. Erratum In: BMC Infect Dis. 2023 Feb 27;23(1):122. doi: 10.1186/s12879-023-08049-7. PubMed 34340679 ↗
  • American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014 Aug;134(2):415-20. doi: 10.1542/peds.2014-1665. Erratum In: Pediatrics. 2014 Dec;134(6):1221. PubMed 25070315 ↗
  • Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010 May 1;375(9725):1545-55. doi: 10.1016/S0140-6736(10)60206-1. PubMed 20399493 ↗
  • Brat R, Yousef N, Klifa R, Reynaud S, Shankar Aguilera S, De Luca D. Lung Ultrasonography Score to Evaluate Oxygenation and Surfactant Need in Neonates Treated With Continuous Positive Airway Pressure. JAMA Pediatr. 2015 Aug;169(8):e151797. doi: 10.1001/jamapediatrics.2015.1797. Epub 2015 Aug 3. PubMed 26237465 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT06204367
Lead sponsor
Kırıkkale University
Responsible party
Sevde Nur Vural (Asistant Doctor, Kırıkkale University) — Principal investigator
First posted
Jan 12, 2024
Start date
Dec 1, 2023
Primary completion
May 1, 2024 (estimated)
Completion
May 1, 2024 (estimated)
Last update
Jan 12, 2024

Study contacts

Sevde Nur nu Vural, Asistant Dr
study chair · KIRIKKALE UNİVERSİTY FACULTY OF MEDİCİNE

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion